Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders |
BOSTON OMAHA Corp (BOMN)
|
Add to portfolio |
|
|
Price: |
$29.61
| | Metrics |
OS: |
30.2
|
M
| |
|
% ROE
|
Market cap: |
$896
|
M
| |
-1
|
% ROIC
|
Net cash:
|
$190
|
M
| |
$6.30
|
per share
|
EV:
|
$705
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$11.5
|
M
| |
61.4
|
x EV/EBITDA
|
EBIT
|
($6.5)
|
M
| |
|
|
EPS |
($0.02)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 81.2 | 57.0 | 45.7 | 41.4 | 20.0 | 9.0 | 3.8 | 0.7 |
Revenue growth | 42.6% | 24.5% | 10.5% | 106.7% | 122.1% | 134.5% | 431.7% | 1547.7% |
Cost of goods sold | 26.3 | 34.2 | 13.0 | 11.9 | 14.2 | 7.9 | 3.0 | 0.5 |
Gross profit | 54.9 | 22.7 | 32.7 | 29.4 | 5.8 | 1.2 | 0.8 | 0.3 |
Gross margin | 67.6% | 39.9% | 71.5% | 71.1% | 28.9% | 12.9% | 21.3% | 34.8% |
General and administrative | 18.2 | 17.5 | 11.2 | 10.0 | 7.7 | 4.1 | 2.0 | 0.9 |
EBITA | 18.3 | -22.7 | 0.8 | -11.7 | -11.6 | -5.6 | -2.3 | -1.0 |
EBITA margin | 22.5% | -39.9% | 1.7% | -28.3% | -58.0% | -61.7% | -60.6% | -141.5% |
Amortization of intangibles | | | | | | 0.8 | 0.6 | 0.0 |
EBIT | 18.3 | -22.7 | 0.8 | -11.7 | -11.6 | -6.3 | -2.9 | -1.0 |
EBIT margin | 22.5% | -39.9% | 1.7% | -28.3% | -58.0% | -70.3% | -75.6% | -141.8% |
Pre-tax income | 3.8 | 73.2 | -2.4 | -1.5 | -9.2 | -6.5 | -3.2 | -1.0 |
Income taxes | -3.5 | 17.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | 24.2% | 0.0% | 0.0% | 0.5% | 0.2% | 0.0% | 0.0% |
Net income | 7.3 | 55.5 | -2.4 | -1.5 | -9.2 | -6.5 | -3.2 | -1.0 |
Net margin | 9.0% | 97.4% | -5.3% | -3.6% | -45.7% | -71.9% | -82.6% | -144.9% |
|
Diluted EPS | $0.24 | $1.91 | ($0.09) | ($0.07) | ($0.46) | ($0.60) | ($0.53) | ($0.71) |
Shares outstanding (diluted) | 29.8 | 29.0 | 25.7 | 22.8 | 19.9 | 10.8 | 6.0 | 1.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|